BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38827745)

  • 1. Activation of TLR9 signaling suppresses the immunomodulating functions of CD55
    Jiang T; Li Y; Huang X; Jayakumar P; Billiar TR; Deng M
    Front Immunol; 2024; 15():1337384. PubMed ID: 38827745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity.
    Xu L; Li Y; Yang C; Loughran P; Liao H; Hoffman R; Billiar TR; Deng M
    J Clin Invest; 2019 Aug; 129(9):3657-3669. PubMed ID: 31380807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblastic reticular cells initiate immune responses in visceral adipose tissues and secure peritoneal immunity.
    Perez-Shibayama C; Gil-Cruz C; Cheng HW; Onder L; Printz A; Mörbe U; Novkovic M; Li C; Lopez-Macias C; Buechler MB; Turley SJ; Mack M; Soneson C; Robinson MD; Scandella E; Gommerman J; Ludewig B
    Sci Immunol; 2018 Aug; 3(26):. PubMed ID: 30097537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
    Nakayama Y; Brinkman CC; Bromberg JS
    Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblastic reticular cells at the nexus of innate and adaptive immune responses.
    Perez-Shibayama C; Gil-Cruz C; Ludewig B
    Immunol Rev; 2019 May; 289(1):31-41. PubMed ID: 30977192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal injection of class A TLR9 agonist enhances anti-PD-1 immunotherapy in colorectal peritoneal metastases.
    Jiang T; Zhang H; Li Y; Jayakumar P; Liao H; Huang H; Billiar TR; Deng M
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36278484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR7/9-mediated monocytosis and maturation of Gr-1(hi) inflammatory monocytes towards Gr-1(lo) resting monocytes implicated in murine lupus.
    Santiago-Raber ML; Baudino L; Alvarez M; van Rooijen N; Nimmerjahn F; Izui S
    J Autoimmun; 2011 Nov; 37(3):171-9. PubMed ID: 21665436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17-dependent fibroblastic reticular cell training boosts tissue protective mucosal immunity through IL-10-producing B cells.
    Wu D; Poholek CH; Majumder S; Liu Q; Revu SK; Mohib K; Rothstein DM; McGeachy MJ
    Sci Immunol; 2021 Dec; 6(66):eaao3669. PubMed ID: 34919443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRC transplantation restores lymph node conduit defects in laminin α4-deficient mice.
    Li L; Wu L; Kensiski A; Zhao J; Shirkey MW; Song Y; Piao W; Zhang T; Mei Z; Gavzy SJ; Ma B; Saxena V; Lee YS; Xiong Y; Li X; Fan X; Abdi R; Bromberg JS
    JCI Insight; 2023 Apr; 8(8):. PubMed ID: 37092548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblastic reticular cells of the lymphoid tissues modulate T cell activation threshold during homeostasis via hyperactive cyclooxygenase-2/prostaglandin E
    Yu M; Guo G; Zhang X; Li L; Yang W; Bollag R; Cui Y
    Sci Rep; 2017 Jun; 7(1):3350. PubMed ID: 28611431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblastic reticular cells provide a supportive niche for lymph node-resident macrophages.
    D'Rozario J; Knoblich K; Lütge M; Shibayama CP; Cheng HW; Alexandre YO; Roberts D; Campos J; Dutton EE; Suliman M; Denton AE; Turley SJ; Boyd RL; Mueller SN; Ludewig B; Heng TSP; Fletcher AL
    Eur J Immunol; 2023 Sep; 53(9):e2250355. PubMed ID: 36991561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFNAR signaling in fibroblastic reticular cells can modulate CD8
    Knop L; Spanier J; Larsen PK; Witte A; Bank U; Dunay IR; Kalinke U; Schüler T
    Eur J Immunol; 2022 Jun; 52(6):895-906. PubMed ID: 35365883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and activation of fibroblastic reticular cells.
    Lütge M; Pikor NB; Ludewig B
    Immunol Rev; 2021 Jul; 302(1):32-46. PubMed ID: 34046914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Engineered Stromal Reticula to Study Lymph Node Fibroblastic Reticular Cells in Type I Diabetes.
    Gonzalez Badillo F; Zisi Tegou F; Masina R; Wright S; Scully M; Harwell L; Lupp M; Postigo-Fernandez J; Creusot RJ; Tomei AA
    Cell Mol Bioeng; 2020 Oct; 13(5):419-434. PubMed ID: 33184575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity.
    Prados A; Onder L; Cheng HW; Mörbe U; Lütge M; Gil-Cruz C; Perez-Shibayama C; Koliaraki V; Ludewig B; Kollias G
    Nat Immunol; 2021 Apr; 22(4):510-519. PubMed ID: 33707780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node fibroblastic reticular cells steer immune responses.
    Li L; Wu J; Abdi R; Jewell CM; Bromberg JS
    Trends Immunol; 2021 Aug; 42(8):723-734. PubMed ID: 34256989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells.
    Cremasco V; Woodruff MC; Onder L; Cupovic J; Nieves-Bonilla JM; Schildberg FA; Chang J; Cremasco F; Harvey CJ; Wucherpfennig K; Ludewig B; Carroll MC; Turley SJ
    Nat Immunol; 2014 Oct; 15(10):973-81. PubMed ID: 25151489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools.
    Valencia J; Jiménez E; Martínez VG; Del Amo BG; Hidalgo L; Entrena A; Fernández-Sevilla LM; Del Río F; Varas A; Vicente Á; Sacedón R
    Cytotherapy; 2017 May; 19(5):640-653. PubMed ID: 28262465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells.
    Choi SY; Bae H; Jeong SH; Park I; Cho H; Hong SP; Lee DH; Lee CK; Park JS; Suh SH; Choi J; Yang MJ; Jang JY; Onder L; Moon JH; Jeong HS; Adams RH; Kim JM; Ludewig B; Song JH; Lim DS; Koh GY
    Nat Commun; 2020 Jan; 11(1):519. PubMed ID: 31980640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs.
    Gil-Cruz C; Perez-Shibayama C; Onder L; Chai Q; Cupovic J; Cheng HW; Novkovic M; Lang PA; Geuking MB; McCoy KD; Abe S; Cui G; Ikuta K; Scandella E; Ludewig B
    Nat Immunol; 2016 Dec; 17(12):1388-1396. PubMed ID: 27798617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.